This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
This is a $150,000.00 Firm Fixed Price contract awarded by the Department of the Army to Critical Innovations LLC, a Limited Liability Company, under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I SBIR effort on the topic of "DIVER PERFORMANCE MONITORING SYSTEM". It is designated as a Total Small Business set-aside. Critical Innovations is an ISO certified, Defense Contract Audit Agency (DCAA) compliant medical research and development company that...
This is a $1,550,000.00 fixed-price level of effort contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business limited liability company. The contract is for the Small Business Innovation Research (SBIR) Phase II project "DHA SBIR PHASE II O2-1681" and has a completion date of December 3, 2021. The contract is designated as a total small business set-aside. Critical Innovations, an ISO 13485:2016 certified medical research and development company,...
This is a $150,000.00 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control". Critical Innovations is an ISO certified and DCAA compliant medical research and development company that has been awarded over $10...
The U.S. Army's Joint PEO Chemical and Biological Defense has awarded a $1,099,999.92 Firm Fixed Price contract to Critical Innovations LLC, a small business medical research and development company, for Phase II of a Small Business Innovation Research (SBIR) program effort. The contract is designated as a total small business set-aside. Critical Innovations will continue development of various advanced medical technologies for military and pre-hospital applications, including solutions for...
This is a $1,550,000.00 Firm Fixed Price, Definitive Contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a for-profit limited liability company, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of the "BurRapid Intracranial Access Platform with QuickICP and QuickVentric Attachments" medical research and development project, with a total small business set-aside designation. Critical Innovations LLC is...
This is a firm fixed-price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract, valued at $1,100,000.00, is for the development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control" as part of a Phase II SBIR effort. Critical Innovations LLC is an ISO certified, DCAA compliant medical research and development company that has been...
This is a $946,809.00 Firm Fixed Price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a for-profit limited liability company. The contract is for the Pleurapath Chest Tube Augmentation and Acceleration Program under the Joint Warfighter Medical Research Program, which is a SBIR Phase III action with no set-aside designation. Critical Innovations LLC is an ISO certified, DCAA compliant medical R&D company that has received over $10...
This federal contract award is for a Phase I Small Business Innovation Research (SBIR) effort by the Department of the Army Medical Command. The contract, valued at $167,500.00, was awarded to Critical Innovations LLC, a for-profit limited liability company focused on medical research and development. The contract is for the development of "Succor Combat Foam for Advanced Wound Care of Traumatized Tissue," which supports the Army's medical research and development efforts. As a Phase I...
The Department of Defense, specifically the Army Medical Command, awarded a $250,000 firm fixed price contract to Critical Innovations LLC of Inglewood, California. The contract is for Phase I of a Small Business Innovation Research proposal related to Department of Defense topic DHA213-009, which involves the development of a wearable wound infection treatment device. The period of performance is from March 25, 2022 through October 24, 2022. The contract has a total small business set aside...